Researchers at the University of Pennsylvania have unveiled an innovative approach to cancer treatment that leverages tiny ...

Researchers at Penn Medicine created an innovative cancer treatment using nano-sized capsules that can target and trigger cancer cell self-destruction.

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical ...

CHICAGO, IL / ACCESS Newswire / January 22, 2025 / ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, ...

Benzimidazole derivatives, originally developed as antiparasitic agents, have garnered attention in recent years for their potential anticancer properties. Research has increasingly focused on ...

Cosmos Health (COSM) has secured buy-out rights and exclusive licensing for two patented anticancer drugs targeting, among others, prostate, ...

With a PhD in Genetics and Genomics, Niki channels her infectious disease research and science communication experiences into her role as a senior science editor for the TS Creative Services team.

Lisata Therapeutics (LSTA) stock lost in reaction to data from a mid-stage trial for its main asset, certepetide, in patients ...

Benzothiazole derivatives have gained significant attention in recent years for their potential as therapeutic agents in both anticancer and antimicrobial research. These compounds, characterized ...

It’s worth thinking about when investigating the increase in colon cancer in young people.

ReiThera has inked a comprehensive Master Service Agreement (MSA) with SillaJen, which establishes ReiThera as the ...

An analysis of oncology drugs approved in the United States found that Medicare spending was predominantly driven by the market, not a drug’s therapeutic value.